Isolation of eudesmanes from Pluchea odorata and evaluation of their effects on cancer cell growth and tumor invasiveness in vitro
- 1 September 2017
- journal article
- Published by Elsevier in Phytochemistry
- Vol. 141, 37-47
Abstract
No abstract availableKeywords
Funding Information
- University of Vienna
- Sino-Austria Project (PP06)
- Herzfelder Family Foundation
This publication has 35 references indexed in Scilit:
- A eudesmane-type sesquiterpene isolated from Pluchea odorata (L.) Cass. combats three hallmarks of cancer cells: Unrestricted proliferation, escape from apoptosis and early metastatic outgrowth in vitroMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2015
- Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cellsInternational Immunopharmacology, 2012
- Cancer and Inflammation: Promise for Biologic TherapyJournal of Immunotherapy, 2010
- G.U.E.S.S.—A Generally Useful Estimate of Solvent Systems for CCCJournal of Liquid Chromatography & Related Technologies, 2005
- Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction2005
- Natural products in anticancer therapyCurrent Opinion in Pharmacology, 2001
- Two New Eudesmane Sesquiterpenes From Pluchea ArgutaNatural Product Letters, 1992
- Three New Eudesmane Sesquiterpenes from Pluchea argutaJournal of Natural Products, 1992
- Odontin and Odonticin, Two New Eudesmane Sesquiterpenes from Pluchea argutaJournal of Natural Products, 1989
- A New Eudesmane Derivative fromPluchea odorataPlanta Medica, 1985